Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Svetlana up on 2024-6-27

Curated date: 2024/03/12

Curator: Fiddyhamma

Revision editor(s): Fiddyhamma, Scholastica

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Mus musculus
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Colon Hindgut,Large bowel,Posterior intestine,Colon,colon
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Clinical treatment Clinical treatment,clinical treatment
Group 0 name Corresponds to the control (unexposed) group for case-control studies
FGF21 + MPTP mice (mice treated with Fibroblast growth factor 21 (FGF21))
Group 1 name Corresponds to the case (exposed) group for case-control studies
MPTP (untreated PD mice)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) induced Parkinson's disease (PD) mice model.
Group 0 sample size Number of subjects in the control (unexposed) group
10
Group 1 sample size Number of subjects in the case (exposed) group
10
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Ion Torrent

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2024-6-27

Curated date: 2024/03/13

Curator: Fiddyhamma

Revision editor(s): Fiddyhamma

Source: Figure 5C, Text

Description: LEfSe analysis with LDA score representing statistical bacterial differences in colonic microbiota between the PD (positive score) and FGF21 groups (negative score).

Abundance in Group 1: increased abundance in MPTP (untreated PD mice)

NCBI Quality ControlLinks
Bacillales
Mammaliicoccus lentus
Staphylococcaceae
Staphylococcus

Revision editor(s): Fiddyhamma

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2024-6-27

Curated date: 2024/03/13

Curator: Fiddyhamma

Revision editor(s): Fiddyhamma

Source: Figure 5C, Text

Description: LEfSe analysis with LDA score representing statistical bacterial differences in colonic microbiota between the PD (positive score) and FGF21 groups (negative score).

Abundance in Group 1: decreased abundance in MPTP (untreated PD mice)

NCBI Quality ControlLinks
Candidatus Saccharimonas
Clostridia
Deltaproteobacteria
Desulfovibrionaceae
Desulfovibrionales
Eubacteriales
Lachnospiraceae
Oscillospiraceae
Ruminiclostridium papyrosolvens
bacterium
unclassified Oscillospiraceae

Revision editor(s): Fiddyhamma